個別化医療バイオマーカー市場：タイプ別、用途別、エンドユーザー別、地域別

世界の個別化医療バイオマーカー市場は、2024年に247億米ドルと推定され、2024年から2031年までのCAGRは15.6％を示し、2031年には681億1,000万米ドルに達すると予測されます。

図.個別化医療バイオマーカー市場シェア（%）、2024年地域別

個別化医療バイオマーカー市場とは、遺伝子情報を活用して患者に最適な治療を計画することを指します。個別化医療は、予測される病気への素因など、個人の特性に合わせた予防薬や治療薬の設計を目的としています。バイオマーカーは、どの患者が特定の治療に適しているかを特定するのに役立つため、個別化医療において重要な役割を果たします。バイオマーカーは、病気のスクリーニング、病気の発症リスクの特定、病気の進行速度の予測、治療に対する反応性の評価に利用できます。遺伝子検査の利用可能性の増加、慢性疾患の有病率の増加、精密医療への注目の高まり、技術の進歩は、世界の個別化医療バイオマーカー市場の成長を促進すると予想される主な要因の一部です。

市場力学：

世界の個別化医療バイオマーカー市場の成長は、世界の慢性疾患および生命を脅かす疾患の有病率の増加、製薬企業による研究開発イニシアチブの高まり、創薬および開発におけるバイオマーカーの応用の増加、精密医療への注目の高まり、バイオマーカー同定における技術進歩、遺伝子検査の利用可能性など、いくつかの要因によって推進されます。しかし、バイオマーカーに基づく検査に関連する高コストと償還政策の欠如が市場成長を抑制すると予想されます。新興経済諸国では、医療費の増加、個別化医療に対する意識の高まり、医療研究助成金の増加などにより、市場開拓の機会が大きく広がっています。新製品の発売、市場参入企業と研究機関との提携、企業による地理的拡大戦略などは、世界の個別化医療バイオマーカー市場における主要なビジネスチャンスです。

本調査の主な特徴

本レポートは、世界の個別化医療バイオマーカー市場を詳細に分析し、2023年を基準年とした予測期間（2024～2031年）の市場規模および複合年間成長率（CAGR%）を提供しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

本調査の対象となる主要企業には、F Roche Diagnostics、Illumina, Inc.、Thermo Fisher Scientific Inc.、QIAGEN N.V.、Agilent Technologies, Inc.、Bio-Rad Laboratories, Inc.、Siemens Healthineers、Abbott Laboratories、Merck KGaA、Genomic Health, Inc.、Myriad Genetics, Inc.、Foundation Medicine, Inc.、Exact Sciences Corporation、Guardant Health, Inc.、Luminex Corporationなどがあります。

このレポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関して、情報に基づいた意思決定を行うことができます。

世界の個別化医療バイオマーカー市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。

世界の個別化医療バイオマーカー市場の分析に使用される様々な戦略マトリックスを通じて、利害関係者は意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• 促進要因
• 抑制要因
• 機会
• 影響分析
• 主な発展
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ
• 業界動向

第4章 世界の個別化医療バイオマーカー市場、タイプ別、2019～2031年

• 遺伝子バイオマーカー
• タンパク質バイオマーカー
• 代謝物バイオマーカー

第5章 世界の個別化医療バイオマーカー市場、用途別、2019～2031年

• 腫瘍学
• 神経学
• 糖尿病
• 自己免疫疾患
• 心臓病学
• その他

第6章 世界の個別化医療バイオマーカー市場、エンドユーザー別、2019～2031年

• 病院
• 診断検査室
• 研究機関

第7章 世界の個別化医療バイオマーカー市場、地域別、2019～2031年

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第8章 競合情勢

• Roche Diagnostics
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• QIAGEN N.V.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers
• Abbott Laboratories
• Merck KGaA
• Genomic Health, Inc.
• Myriad Genetics, Inc.
• Foundation Medicine, Inc.
• Exact Sciences Corporation
• Guardant Health, Inc.
• Luminex Corporation

第9章 アナリストの推奨事項

• 運命の輪
• アナリストの見解
• 一貫した機会マップ

第10章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

Global personalized medicine biomarkers market is estimated to be valued at USD 24.70 Bn in 2024 and is expected to reach USD 68.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 15.6% from 2024 to 2031.

Figure. Personalized Medicine Biomarkers Market Share (%), By Region 2024

Personalized medicine biomarkers market refers to the utilization of genetic information to plan the most suitable treatment for patients. Personalized medicine aims to design preventive or therapeutic products tailored to an individual's characteristics, including their predicted predisposition to illness. Biomarkers play an important role in personalized medicine as they help identify which patients are suitable for specific treatments. Biomarkers can be utilized to screen for diseases, identify the risk of developing a disease, predict the rate of disease progression, and assess the response to treatment. Increasing availability of genetic tests, growing prevalence of chronic diseases, rising focus on precision medicine, and technological advancements are some of the key factors expected to propel the growth of the global personalized medicine biomarkers market.

Market Dynamics:

Global personalized medicine biomarkers market growth is driven by several factors such as growing prevalence of chronic and life-threatening diseases worldwide, rising R&D initiatives by pharmaceutical companies, increasing application of biomarkers in drug discovery and development, growing focus on precision medicine, technological advancements in biomarker identification, and availability of genetic tests. However, high costs associated with biomarker-based tests and lack of reimbursement policies are expected to restrain the market growth. The market players have significant opportunities in developing economies owing to growing healthcare expenditure, rising awareness about personalized medicine, and increasing healthcare research grants. New product launches, collaborations between market players and research institutes, and geographical expansion strategies by companies are some key opportunities in the global personalized medicine biomarkers market.

Key Features of the Study:

This report provides in-depth analysis of the global personalized medicine biomarkers market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

Key companies covered as a part of this study include F Roche Diagnostics, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Siemens Healthineers, Abbott Laboratories, Merck KGaA, Genomic Health, Inc., Myriad Genetics, Inc., Foundation Medicine, Inc., Exact Sciences Corporation, Guardant Health, Inc., and Luminex Corporation

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global personalized medicine biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized medicine biomarkers market

Market Segmentation

• Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Genetic Biomarkers
  • Protein Biomarkers
  • Metabolite Biomarkers
• Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Oncology
  • Neurology
  • Diabetes
  • Autoimmune Diseases
  • Cardiology
  • Others
• End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Roche Diagnostics
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers
  • Abbott Laboratories
  • Merck KGaA
  • Genomic Health, Inc.
  • Myriad Genetics, Inc.
  • Foundation Medicine, Inc.
  • Exact Sciences Corporation
  • Guardant Health, Inc.
  • Luminex Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Personalized Medicine Biomarkers Market, By Type
  • Global Personalized Medicine Biomarkers Market, By Application
  • Global Personalized Medicine Biomarkers Market, By End User
  • Global Personalized Medicine Biomarkers Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Personalized Medicine Biomarkers Market, By Type, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Genetic Biomarkers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Protein Biomarkers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Metabolite Biomarkers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Personalized Medicine Biomarkers Market, By Application, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Autoimmune Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Personalized Medicine Biomarkers Market, By End User, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Personalized Medicine Biomarkers Market, By Region, 2019 - 2031, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Illumina, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QIAGEN N.V.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Genomic Health, Inc.
• Myriad Genetics, Inc.
• Foundation Medicine, Inc.
• Exact Sciences Corporation
• Guardant Health, Inc.
• Luminex Corporation

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us